Advanced Medical Solutions Grp PLC Total Voting Rights (9222R)
October 31 2023 - 1:02PM
UK Regulatory
TIDMAMS
RNS Number : 9222R
Advanced Medical Solutions Grp PLC
31 October 2023
31 October 2023
Advanced Medical Solutions Group plc
("AMS" or the "Group")
Total Voting Rights
In accordance with Disclosure and Transparency Rule 5.6.1, the
issued share capital of Advanced Medical Solutions Group plc as at
31 October 2023 comprises 217,296,349 ordinary shares of 5p each
with voting rights. There are no shares held in treasury.
The above figure may be used by shareholders as the denominator
for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest
in, the Company under the FCA's Disclosure and Transparency
Rules.
-Ends-
For further information, please visit www.admedsol.com or
contact:
Advanced Medical Solutions Group plc Tel: +44 (0) 1606
545508
Chris Meredith, Chief Executive Officer
Eddie Johnson, Chief Financial Officer
Michael King, Investor Relations
ICR Consilium Tel: +44 (0) 20 3709
5700
Matthew Neal / Lucy Featherstone AMS@consilium-comms.com
Investec Bank plc ( NOMAD and Broker ) Tel: +44 (0) 20 7597
5970
Gary Clarence / David Anderson
HSBC Bank plc (Broker) Tel: 44 (0) 20 7991
Sam McLennan / Joe Weaving / Stephanie 8888
Cornish
About Advanced Medical Solutions Group plc
AMS is a world-leading independent developer and manufacturer of
innovative tissue-healing technology, focused on quality outcomes
for patients and value for payers. AMS has a wide range of surgical
products including tissue adhesives, sutures, haemostats, internal
fixation devices and internal sealants, which it markets under its
brands LiquiBand(R) , RESORBA(R) , LiquiBandFix8(R) and Seal-G(R) .
AMS also supplies wound care dressings such as silver alginates,
alginates and foams through its ActivHeal(R) brand as well as under
white label. Since 2019, the Group has made five acquisitions:
Sealantis, an Israeli medical device company with a
patent-protected sealant technology platform; Biomatlante, an
established French developer and manufacturer of innovative
surgical biomaterial technologies, Raleigh, a UK leading coater and
converter of materials predominately for woundcare and
bio-diagnostics products, AFS Medical, an Austrian a specialist
surgical business with a focus on minimally invasive procedures,
and Connexicon Medical, an Irish tissue adhesives specialist.
AMS's products, manufactured in the UK, Germany, France, the
Netherlands, the Czech Republic and Israel, are sold globally via a
network of multinational or regional partners and distributors, as
well as via AMS's own direct sales forces in the UK, Germany,
Austria, the Czech Republic and Russia. The Group has R&D
innovation hubs in the UK, Germany, France, Ireland and Israel.
Established in 1991, the Group has more than 800 employees. For
more information, please see www.admedsol.com .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
TVREAXEFDEEDFFA
(END) Dow Jones Newswires
October 31, 2023 13:02 ET (17:02 GMT)
Advanced Medical Solutions (AQSE:AMS.GB)
Historical Stock Chart
From Jul 2024 to Aug 2024
Advanced Medical Solutions (AQSE:AMS.GB)
Historical Stock Chart
From Aug 2023 to Aug 2024